NCT07791719

Brief Summary

This study aims to compare the clinical effectiveness of three PICC (Peripherally Inserted Central Catheter) insertion methods: conventional non-tunneled PICC, one-needle tunneled PICC, and two-needle tunneled PICC. This is a multicenter randomized controlled trial involving 11 hospitals in China, with a total of 801 patients scheduled to undergo PICC insertion for the first time. Patients will be randomly assigned in a 1:1:1 ratio to the three groups. The primary outcome is the incidence of post-insertion complications (including oozing, infection, thrombosis, catheter dislodgement, etc.) within 90 days. Secondary outcomes include one-time puncture success rate, pain level (NRS), bleeding volume, catheterization time, and unplanned catheter removal rate. The results will provide evidence for selecting the optimal PICC insertion method in clinical practice.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
801

participants targeted

Target at P75+ for not_applicable

Timeline
12mo left

Started Sep 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 25, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 28, 2026

Completed
13 days until next milestone

Study Start

First participant enrolled

September 10, 2026

Expected
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2027

3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2027

Last Updated

August 28, 2026

Status Verified

August 1, 2026

Enrollment Period

9 months

First QC Date

August 25, 2026

Last Update Submit

August 25, 2026

Conditions

Keywords

Peripherally inserted central catheters ; tunneled; complications

Outcome Measures

Primary Outcomes (1)

  • Overall Incidence of Catheter-Related Complications Within 90 Days Post-catheterization

    The composite endpoint includes: oozing/exudation at the catheter exit site, mechanical phlebitis, catheter-related bloodstream infection, local or tunnel infection, catheter-related thrombosis, catheter dislodgement or migration, catheter occlusion, contact dermatitis, and catheter breakage or damage. All complications are assessed from the day of insertion up to 90 days post-insertion.

    From catheterization to 90 days post-catheterization

Secondary Outcomes (5)

  • One-Time Puncture Success Rate

    Day 1 During catheterization procedure

  • Pain Intensity During Catheterization (NRS Score)

    Day 1 Immediately after catheterization procedure

  • Intraoperative Bleeding Volume

    Day 1 From start to end of catheterization procedure

  • Catheterization Procedure Time

    Day 1 During catheterization procedure

  • Unplanned Catheter Removal Rate

    From Day 1 catheterization to 90 days post-catheterization

Study Arms (3)

Conventional Non-Tunneled PICC catheterization

ACTIVE COMPARATOR

Patients receive conventional non-tunneled PICC insertion. The procedure involves ultrasound-guided vein puncture, guidewire insertion, local anesthesia and skin dilation, followed by sheath and catheter advancement. The catheter exit site is at the puncture site.

Procedure: Conventional Non-Tunneled PICC catheterization

One-Needle Tunneled PICC catheterization

EXPERIMENTAL

Patients receive one-needle tunneled PICC insertion. The puncture needle travels subcutaneously for 4 cm before entering the vessel, creating a subcutaneous tunnel. The skin puncture and catheter exit sites are the same. This technique requires only one needle pass for both tunneling and vessel puncture.

Procedure: One-Needle Tunneled PICC catheterization

Two-Needle Tunneled PICC catheterization

EXPERIMENTAL

Patients receive two-needle tunneled PICC insertion. Ultrasound-guided vein puncture is performed first, followed by creation of a 4 cm subcutaneous tunnel using a tunneling tool. The puncture site and catheter exit site are separate, with a subcutaneous tunnel connecting them.

Procedure: Two-Needle Tunneled PICC catheterization

Interventions

Ultrasound-guided vein puncture, followed by guidewire insertion, local anesthesia, skin dilation, sheath advancement, and catheter delivery. The catheter exit site is at the puncture site with no subcutaneous tunnel created.

Conventional Non-Tunneled PICC catheterization

The puncture needle travels subcutaneously for 4 cm before entering the vessel, creating a subcutaneous tunnel with a single needle pass. The puncture site and catheter exit site are the same. This technique combines tunneling and vessel puncture in one step.

One-Needle Tunneled PICC catheterization

A two-step procedure: first, ultrasound-guided vein puncture is performed; then, a separate subcutaneous tunnel of 4 cm is created using a tunneling tool. The puncture site and catheter exit site are separate, connected by a subcutaneous tunnel. The catheter is pulled through the tunnel from the exit site to the puncture site.

Two-Needle Tunneled PICC catheterization

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 to 75 years
  • Education level of primary school or above, with adequate reading, writing and --communication skills to independently complete the questionnaire
  • First-time PICC insertion using a 4Fr single-lumen solo PICC catheter
  • Able to attend follow-up visits at the same hospital for catheter maintenance after insertion
  • Willing to participate in the study and sign the informed consent form and PICC insertion consent form

You may not qualify if:

  • Coagulation dysfunction (INR \> 1.5 or PLT \< 25 × 10⁹/L)
  • Use of anticoagulants (e.g., warfarin, heparin) within 3 days before catheterization
  • Pregnant or lactating women
  • BMI \< 18.5 kg/m²
  • Patients requiring lower extremity PICC insertion
  • Known or suspected allergy to components of the PICC catheter

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sun Yat-sen University Cancer Center

Guangzhou, Guangdong, 510000, China

Location

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
specialist nurse

Study Record Dates

First Submitted

August 25, 2026

First Posted

August 28, 2026

Study Start (Estimated)

September 10, 2026

Primary Completion (Estimated)

May 30, 2027

Study Completion (Estimated)

August 30, 2027

Last Updated

August 28, 2026

Record last verified: 2026-08

Locations